242 related articles for article (PubMed ID: 16723307)
1. Serum leptin concentrations in pre- and postmenopausal women on sex hormone therapy.
Bednarek-Tupikowska G; Filus A; Kuliczkowska-Płaksej J; Tupikowski K; Bohdanowicz-Pawlak A; Milewicz A
Gynecol Endocrinol; 2006 Apr; 22(4):207-12. PubMed ID: 16723307
[TBL] [Abstract][Full Text] [Related]
2. Serum leptin levels and body weight in postmenopausal women under transdermal hormone replacement therapy.
Salbach B; Nawroth PP; Kübler W; von Holst Th; Salbach PB
Eur J Med Res; 2000 Feb; 5(2):63-6. PubMed ID: 10720565
[TBL] [Abstract][Full Text] [Related]
3. Serum estrogen level after hormone replacement therapy and body mass index in postmenopausal and bilaterally ovariectomized women.
Yasui T; Uemura H; Umino Y; Takikawa M; Saito S; Kuwahara A; Matsuzaki T; Maegawa M; Furumoto H; Miura M; Irahara M
Maturitas; 2005 Jan; 50(1):19-29. PubMed ID: 15590210
[TBL] [Abstract][Full Text] [Related]
4. Correlation of Kupperman's index with estrogen and androgen levels, according to weight and body fat distribution in postmenopausal women from Mexico City.
Carranza-Lira S; Velasco Díaz G; Olivares A; Chán Verdugo R; Herrera J
Int J Fertil Womens Med; 2006; 51(2):83-8. PubMed ID: 16881384
[TBL] [Abstract][Full Text] [Related]
5. Relationships between plasma leptin levels and body composition parameters measured by different methods in postmenopausal women.
Jürimäe T; Sudi K; Jürimäe J; Payerl D; Rüütel K
Am J Hum Biol; 2003; 15(5):628-36. PubMed ID: 12953174
[TBL] [Abstract][Full Text] [Related]
6. Relationship of leptin concentration to gender, body mass index and age in Saudi adults.
Al-Harithy RN
Saudi Med J; 2004 Aug; 25(8):1086-90. PubMed ID: 15322603
[TBL] [Abstract][Full Text] [Related]
7. Effect of hormone replacement therapy and tibolone on serum leptin levels in postmenopausal women.
Lambrinoudaki IV; Christodoulakos GE; Panoulis CP; Rizos DA; Dendrinos SG; Liakakos T; Augoulea AD; Creatsas GC
Maturitas; 2004 Jun; 48(2):107-13. PubMed ID: 15172084
[TBL] [Abstract][Full Text] [Related]
8. Effects of oral continuous 17beta-estradiol plus norethisterone acetate replacement therapy on abdominal subcutaneous fat, serum leptin levels and body composition.
Yüksel H; Odabaşi AR; Demircan S; Karul A; Kozaci LD; Köseoğlu K; Kizilkaya K; Başak O
Gynecol Endocrinol; 2006 Jul; 22(7):381-7. PubMed ID: 16864148
[TBL] [Abstract][Full Text] [Related]
9. Influence of obesity and menopausal status on serum leptin, cholecystokinin, galanin and neuropeptide Y levels.
Milewicz A; Bidzińska B; Mikulski E; Demissie M; Tworowska U
Gynecol Endocrinol; 2000 Jun; 14(3):196-203. PubMed ID: 10923281
[TBL] [Abstract][Full Text] [Related]
10. Serum adiponectin concentration and cardiovascular risk factors in climacteric women.
Milewicz A; Zatonska K; Demissie M; Jêdrzejuk D; Dunajska K; Ilow R; Lwow F
Gynecol Endocrinol; 2005 Feb; 20(2):68-73. PubMed ID: 15823824
[TBL] [Abstract][Full Text] [Related]
11. Interrelationships of serum estradiol, estrone, and estrone sulfate, adiposity, biochemical bone markers, and leptin in post-menopausal women.
Castracane VD; Kraemer GR; Ogden BW; Kraemer RR
Maturitas; 2006 Jan; 53(2):217-25. PubMed ID: 15913927
[TBL] [Abstract][Full Text] [Related]
12. Serum leptin levels and body composition in postmenopausal women treated with tibolone and raloxifene.
Tommaselli GA; Di Carlo C; Di Spiezio Sardo A; Bifulco G; Cirillo D; Guida M; Capasso R; Nappi C
Menopause; 2006; 13(4):660-8. PubMed ID: 16837888
[TBL] [Abstract][Full Text] [Related]
13. Plasma leptin in postmenopausal women with coronary artery disease: effect of transdermal 17beta-estradiol and intermittent medroxyprogesterone acetate.
Os I; Os A; Abdelnoor M; Larsen A; Birkeland K; Westheim A
Climacteric; 2003 Sep; 6(3):204-10. PubMed ID: 14567768
[TBL] [Abstract][Full Text] [Related]
14. Effect of climacteric transition and hormone replacement therapy on body weight and body fat distribution.
Genazzani AR; Gambacciani M
Gynecol Endocrinol; 2006 Mar; 22(3):145-50. PubMed ID: 16835076
[TBL] [Abstract][Full Text] [Related]
15. Effect of postmenopause and hormone replacement therapy on serum adiponectin levels.
Sieminska L; Wojciechowska C; Niedziolka D; Marek B; Kos-Kudla B; Kajdaniuk D; Nowak M
Metabolism; 2005 Dec; 54(12):1610-4. PubMed ID: 16311093
[TBL] [Abstract][Full Text] [Related]
16. Does tibolone affect serum leptin levels and body weight in postmenopausal women?
Gol M; Ozsener S; Sendag F; Uretmen S; Oztekin K; Tanyalcin T; Bilgin O
Arch Gynecol Obstet; 2005 Jul; 272(2):127-30. PubMed ID: 15517326
[TBL] [Abstract][Full Text] [Related]
17. Abdominal fat distribution in pre- and postmenopausal women: The impact of physical activity, age, and menopausal status.
Kanaley JA; Sames C; Swisher L; Swick AG; Ploutz-Snyder LL; Steppan CM; Sagendorf KS; Feiglin D; Jaynes EB; Meyer RA; Weinstock RS
Metabolism; 2001 Aug; 50(8):976-82. PubMed ID: 11474488
[TBL] [Abstract][Full Text] [Related]
18. Circadian serum levels of dehydroepiandrosterone sulphate in postmenopausal asthmatic women before and after long-term hormone replacement.
Kos-Kudla B; Ostrowska Z; Marek B; Ciesielska-Kopacz N; Kudla M; Kajdaniuk D; Siemidska L; Strzelczyk J
Endocr Regul; 2001 Dec; 35(4):217-22. PubMed ID: 11858769
[TBL] [Abstract][Full Text] [Related]
19. Obesity among children and adolescents with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Völkl TM; Simm D; Beier C; Dörr HG
Pediatrics; 2006 Jan; 117(1):e98-105. PubMed ID: 16396852
[TBL] [Abstract][Full Text] [Related]
20. [Absence of antiosteopenic effect of hormone replacement therapy in postmenopausal women].
Ortiz Núñez DA; Mengchún López G; Hernández Marín I; Mendoza R; Ayala Ruíz AR
Ginecol Obstet Mex; 2004 Jul; 72():349-55. PubMed ID: 15469174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
